Lacosamide 69367-0350
Product NDC
69367-0350- Manufacturer
- Westminster Pharmaceuticals, Llc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- July 10, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA205237
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 150 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(1)
60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69367-350-60)